| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3791768 | Medical Clinics of North America | 2007 | 21 Pages |
Abstract
Acute coronary syndromes (ACSs), which include the clinical entities of unstable angina (UA), non–ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), account for more than 1.5 million hospital admissions annually in the United States alone. Approximately 1 million of these admissions are classified as UA/NSTEMI and approximately 500,000 are STEMI. Because of the overwhelming number of studies on ACSs over the past several years, this article focuses on new trials and therapies for treating patients diagnosed with STEMI.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Richard J. Gumina,